CNSP insider trading
NasdaqCM HealthcareCNS Pharmaceuticals, Inc.: insider trade history from SEC Form 4 filings.
About CNS Pharmaceuticals, Inc.
CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, develops anti-cancer drug candidates for the treatment of brain and central nervous system (CNS) tumors. The company's drug candidates include TPI 287 and Berubicin, which are in Phase 2 clinical trial for the treatment of glioblastoma and other CNS malignancies. It has license agreement with Cortice Biosciences, Inc. The company was incorporated in 2017 and is headquartered in Houston, Texas.
Company website: www.cnspharma.com
CNSP insider activity at a glance
FilingIQ tracks 41 insider transactions for CNSP in filings since Aug 25, 2020. The most recent transaction is dated Aug 14, 2026.
Across the full history, 15 open-market purchases
and 17 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on CNSP insider trades is 66.8/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Latest CNSP Form 4 filings
Most recent disclosures. Sign up to filter by score, transaction code, or insider role.
Other Healthcare tickers with recent insider activity
Top insiders trading CNSP
Frequently asked
- How many insider trades does FilingIQ track for CNSP?
- FilingIQ tracks 41 Form 4 insider transactions for CNSP (CNS Pharmaceuticals, Inc.), covering filings from Aug 25, 2020 onwards. 1 of those are dated within the last 90 days.
- Are CNSP insiders net buyers or net sellers?
- Across the full Form 4 history for CNSP, 15 transactions (37%) were open-market purchases and 17 (41%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does CNSP insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.
- What sector is CNSP in?
- CNS Pharmaceuticals, Inc. (CNSP) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $1.77M.
Methodology & sources
Every CNSP insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.